குவாலிட்டி மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குவாலிட்டி மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குவாலிட்டி மருந்துகள் Today - Breaking & Trending Today

Rs 60 to Rs 639: This stock turned into a multibagger in six months

Rs 60 to Rs 639: This stock turned into a multibagger in six months
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Kwality Pharmaceuticals , Hikal Ltd , Divis Labs , Aarti Drugs , Additional Surveillance Measures , குவாலிட்டி மருந்துகள் , டிவிஸ் ஆய்வகங்கள் , ஆர்த்தி மருந்துகள் ,

Activist Yogita Bhayana moves HC over Remdesivir supply

Activist Yogita Bhayana moves HC over Remdesivir supply
ANI
06 May 2021, 21:55 GMT+10
New Delhi [India], May 6 (ANI): Social Activist Yogita Bhayana moved the Delhi High Court seeking direction to Kwality Pharmaceuticals Limited to supply the available units of the Remdesivir and further directed it to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi.
Issue a Writ of Mandamus or any other appropriate Writ, Order or Direction thereby directing the Respondents-UOI to direct respondent number four (Kwality Pharmaceuticals Limited) to supply the available units of the Remdesivir and further direct to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi, said the petition filed through advocates Shrish Kumar and Pramod Kumar. ....

New Delhi , Shrish Kumar , Pramod Kumar , Yogita Bhayana , Kwality Pharmaceuticals , Pharmaceuticals Company , Delhi High Court , Social Activist Yogita Bhayana , Kwality Pharmaceuticals Limited , Bussiness Head , புதியது டெல்ஹி , பிரமோத் குமார் , யோகிதா பயானா , குவாலிட்டி மருந்துகள் , மருந்துகள் நிறுவனம் , டெல்ஹி உயர் நீதிமன்றம் , குவாலிட்டி மருந்துகள் வரையறுக்கப்பட்டவை ,

Activist Yogita Bhayana moves HC seeking direction to Kwality Pharmaceuticals to supply available units of Remdesivir

Representative image
ANI |
Updated: May 06, 2021 16:36 IST
New Delhi [India], May 6 (ANI): Social Activist Yogita Bhayana moved the Delhi High Court seeking direction to Kwality Pharmaceuticals Limited to supply the available units of the Remdesivir and further directed it to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi.
Issue a Writ of Mandamus or any other appropriate Writ, Order or Direction thereby directing the Respondents-UOI to direct respondent number four (Kwality Pharmaceuticals Limited) to supply the available units of the Remdesivir and further direct to use the full capacity to manufacture/produce the Remdesivir and supply the same to the hospitals and public of Delhi, said the petition filed through advocates Shrish Kumar and Pramod Kumar. ....

New Delhi , Shrish Kumar , Pramod Kumar , Yogita Bhayana , Kwality Pharmaceuticals , Pharmaceuticals Company , Delhi High Court , Social Activist Yogita Bhayana , Kwality Pharmaceuticals Limited , Bussiness Head , புதியது டெல்ஹி , பிரமோத் குமார் , யோகிதா பயானா , குவாலிட்டி மருந்துகள் , மருந்துகள் நிறுவனம் , டெல்ஹி உயர் நீதிமன்றம் , குவாலிட்டி மருந்துகள் வரையறுக்கப்பட்டவை ,

Amritsar Remdesivir exporter seeks nod for local sale

Amritsar, April 27
To overcome the shortage and bring down the price of Remdesivir, Amritsar-based Kwality Pharmaceuticals has approached the Union Government, seeking nod for the sale of this anti-viral drug in the domestic market.
Only seven Indian companies have the rights to produce and sell Remdesivir injection locally under agreement with US-based Gilead Sciences. Kwality Pharmaceuticals is among other firms that can only manufacture and export the drug.
It has a capacity to produce 50,000 doses a day. The firm has sought temporary exemption from patent laws from the Central Drugs Standard Control Organisation.
Ramesh Arora, MD, Kwality Pharmaceuticals, said, “Though the Centre has put curbs on Remdesivir export, norms must be relaxed so that we can sell the drug locally to overcome its shortage. The injection can be made available for just Rs 1,500.” ....

Ramesh Arora , Surinder Duggal , Kwality Pharmaceuticals , Union Government , Gilead Sciences , Punjab Pharmaceutical Association , Tribune News Service , Central Drugs Standard Control Organisation , Amritsar Based Kwality Pharmaceuticals , Central Drugs Standard Control , Pharmaceutical Association , ரமேஷ் அரோரா , சுரிண்தேர் டுக்கள் , குவாலிட்டி மருந்துகள் , தொழிற்சங்கம் அரசு , கிலியட் அறிவியல் , ட்ரிப்யூன் செய்தி சேவை , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , மைய மருந்துகள் தரநிலை கட்டுப்பாடு , மருந்து சங்கம் ,